MDWerks, Inc. has filed a Form 15 with the Securities and Exchange Commission to deregister its common stock and suspend its SEC reporting obligations. The decision was made by the Board of Directors after a review with legal counsel and advisors, citing the high cost of compliance relative to the company's size.
The company states that the annual costs of being an SEC-reporting entity are significant. Specifically, public company audit fees were approximately $140,000 last year, compared to annual revenue of about $2.2 million. The filing indicates that deregistration is expected to save the company approximately $200,000 per year.
MDWerks intends to maintain its quotation on the OTC Markets Pink tier and will provide financial information through the OTC Markets Alternative Reporting Standard. The company will no longer file Forms 10-K, 10-Q, or 8-K with the SEC. Instead, reports will be available through OTC Markets.
The Board of Directors outlined several commitments to shareholders, including issuing regular updates via press releases and periodically evaluating the appropriate level of independent financial review or audit. The company noted that deregistration does not change the number of shares held by existing shareholders or their ownership percentage.
The filing also highlighted potential tradeoffs. It stated that deregistration may materially affect the ability of holders of restricted securities to resell their shares under Rule 144. Additionally, the company noted that while it intends to maintain eligibility for quotation on OTC Markets, continued trading liquidity cannot be guaranteed.
MDWerks stated that its priorities remain advancing RF Specialties' industrial manufacturing business, pursuing partnerships such as a proposed joint venture with Rex Lumber Company, and supporting sales of its Spirits Rapid Aging System.